MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

497864

Report Date :

19.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

JANANI PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

No.217, Defence Officers Colony, Nandambakkam, Ekkattuthangal,  Chennai – 600032, Tamilnadu

Tel. No.:

91-44-65392500

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

01.06.2001

 

 

Com. Reg. No.:

18-047192

 

 

Capital Investment / Paid-up Capital :

INR 2.071 Million

 

 

CIN No.:

[Company Identification No.]

U51397TN2001PTC047192

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACJ9878L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subejct is engaged in the business of trading in bulk drugs and pharmaceutical products of various types and also indenting agents for pharmaceutical  companies. [Registered Activity]

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2001 and it is a trader of ulk drugs and pharmaceutical products.

 

As per financials of March 2017, the company has registdered a decline at in its revenue as compared to its previous year’s revenue and has reported average profit margin of 2.03%.

 

Rating takes into consideration the company’s established track record of busienss operations marked by sound networth base along with low solvency indicators and decent liquidity position.

 

Further, the company has reported a good eqrnings per share of INR 49.00 against its face value of INR 10.

 

Payments terms are seems to be usually correct.

 

In view of aforesaid, the subject can be considered for busienss dealings at usual trade terms and conditions.

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 19.03.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Raghhunaathan Ramaswamy

Designation :

Whole Time Director

Contact No.:

91-9840706273

Date :

19.03.2018

 

 

LOCATIONS

 

Registered Office :

No.217, Defence Officers Colony, Nandambakkam, Ekkattuthangal,  Chennai -600032, Tamilnadu, India

Tel. No.:

91-44-65392500

Mobile No.:

91-9840706273 (Mr. Raghhunaathan Ramaswamy)

Fax No.:

Not Available

E-Mail :

jananipharmaceuticals@gmail.com

 

 

DIRECTORS

 

AS ON 31.03.2017

 

Name :

Mr. Raghhunaathan Ramaswamy

Designation :

Whole Time Director

Address :

New No.4A, Old No.849, 91st Street, 13th Sector, K.K. Nagar, Chennai- 600078, Tamilnadu, India

Date of Birth/Age :

11.05.1952

Date of Appointment :

30.11.2016

DIN No.:

01819909

Other Directorship:

CIN/FCRN

Company Name

Begin Date

End Date

U24232PY2009PTC002373

DAEIOU PHARMACEUTICALS PRIVATE LIMITED

21/10/2009

-

 

 

Name :

Mr. Rada Ragunathan

Designation :

Whole Time Director

Address :

New No.4A, Old No.849, 91st Street, 13th Sector, K.K. Nagar, Chennai- 600078, Tamilnadu, India

Date of Birth/Age :

28.05.1958

Date of Appointment :

01.06.2001

DIN No.:

01820874

 

 

 

 

 

 

MAJOR SHAREHOLDERS

 

AS ON 31.03.2017

 

Names of Shareholders

 

No. of Shares

R Raghunaathan

 

60330

Rada Ragunathan

 

98170

R Sribargav

 

15567

R Jaganathan

 

21500

K Sudarsan

 

11500

 

 

 

Total

 

207067

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 30.09.2017

 

Category

Percentage

Promoters [Individual/Hindu Undivided Family (Indian)]

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subejct is engaged in the business of trading in bulk drugs and pharmaceutical products of various types and also indenting agents for pharmaceutical  companies. [Registered Activity]

 

 

Products / Services :

Name and Description of main products / services

ITC Code

Pharmaceutical products

99611730

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

Customers :

 

Reference :

Not Divulged 

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark :

--

 

 

No. of Employees :

Information denied by the management

 

 

 

Bankers :

Banker Name :

ICICI Bank Limited

Branch :

New No.69, Old No.137A, Jawaharlal Nehru Road, Ekkatuthangal, Chennai – 600032, Tamilnadu, India

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Facilities :

SECURED LOANS

31.03.2017

INR In Million

31.03.2016

INR In Million

LONG TERM BORROWINGS

 

 

Term loans from banks

 

 

From ICICI – Housing Loan

Hypothecated – 84 Property

CC Loan

19.960

10.681

 

 

 

Total

19.960

10.681

 

 

Auditors :

 

Name :

LDR and Associates

Chartered Accountants

Address :

New No. 22, Old No.20, Govindu Street, T. Nagar, Chennai – 600017, Tamilnadu, India

Mobile No.:

91-9445224801/9789803566

E-Mail :

blakshmica@gmail.com

revking12@gmail.com

PAN No.:

AAEFL4112E

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Other Related Parties :

·         Daeiou Pharmaceuticals Private Limited

·         Arien RR Impex

·         Ace Pack

·         Narsing Invent Industrial Chemicals

 

 

 

 

CAPITAL STRUCTURE

 

AS ON 30.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

INR 10/- each

INR 2.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

207067

Equity Shares

INR 10/- each

INR 2.071 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.071

2.071

2.071

(b) Reserves & Surplus

106.621

96.545

84.950

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

108.692

98.616

87.021

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

19.960

10.681

13.530

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) Long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

19.960

10.681

13.530

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

115.926

134.999

165.696

(c) Other current liabilities

3.007

4.725

23.105

(d) Short-term provisions

6.514

8.134

19.812

Total Current Liabilities (4)

125.447

147.858

208.613

 

 

 

 

TOTAL

254.099

257.155

309.164

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

30.281

30.088

31.549

(ii) Intangible Assets

0.004

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.170

(c) Deferred tax assets (net)

0.149

0.184

0.179

(d) Long-term Loan and Advances

0.268

1.448

0.413

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

30.702

31.720

32.311

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

19.079

14.690

8.202

(c) Trade receivables

187.177

200.613

254.814

(d) Cash and cash equivalents

12.511

0.446

0.111

(e) Short-term loans and advances

4.630

9.686

13.726

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

223.397

225.435

276.853

 

 

 

 

TOTAL

254.099

257.155

309.164

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Income

497.267

620.981

733.907

 

 

Other Income

11.802

8.826

12.632

 

 

TOTAL                                               

509.069

629.807

746.539

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

475.561

604.982

690.021

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

(4.389)

(18.574)

11.838

 

 

Employee Benefits Expenses

14.469

9.531

7.583

 

 

Other expenses

5.361

7.783

6.354

 

 

Extraordinary items

0.000

5.390

 0.000

 

 

TOTAL                                    

491.002

609.112

715.796

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

18.067

20.695

30.743

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

1.733

1.629

2.316

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

16.334

19.066

28.427

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                    

1.217

1.144

1.491

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

15.117

17.922

26.936

 

 

 

 

 

Less

TAX                                                                 

5.041

6.326

9.035

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

10.076

11.596

17.901

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

49.00

56.00

86.45

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

 

 

 

Directors current account

0.275

0.820

NA

Advance from customers

0.000

2.131

NA

Total

0.275

2.951

NA

 

 

 

 

Cash generated from operations

NA

NA

(7.816)

Net cash flow from operating activities

3.628

4.768

(7.816)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

137.39

117.92

126.73

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

2.66

3.10

2.88

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

88.97

81.45

87.65

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.95

1.41

3.75

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

0.60

0.69

0.97

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.57

0.63

0.72

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.19

0.14

0.16

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

1.15

1.50

2.40

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.28

0.31

0.36

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

10.43

12.70

13.27

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

PAT to Sales

((PAT / Sales) * 100)

%

2.03

1.87

2.44

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

3.97

4.51

5.79

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

9.27

11.76

20.57

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.78

1.52

1.33

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

1.63

1.43

1.29

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.43

0.38

0.28

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

9.77

6.58

6.53

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.78

1.52

1.33

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

2.071

2.071

2.071

Reserves & Surplus

84.950

96.545

106.621

Net worth

87.021

98.616

108.692

 

 

 

 

Long Term borrowings

13.530

10.681

19.960

Short Term borrowings

0.000

0.000

0.000

Total borrowings

13.530

10.681

19.960

Debt/Equity ratio

0.155

0.108

0.184

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

733.907

620.981

497.267

 

 

(15.387)

(19.922)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

733.907

620.981

497.267

Profit/(Loss)

17.901

11.596

10.076

 

2.44%

1.87%

2.03%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

BACKGROUND:

 

The Company is in the business of trading in Bulk Drugs and Pharmaceutical products of various types and also indenting agents for pharmaceutical companies situated in India. During the year, the major source of revenue is from sale of Pharma products and Commission and service charges on indenting.

 

 

HIGHLIGHT OR SUMMARY OF THE FINANCIAL STATEMENT:

 

The revenue of the company has reduced from INR 620.981 million during the previous year to INR 497.267 million in the current year. The profit after tax was INR 10.076 million during the financial year compared to INR 11.596 million in the previous year. The company has also managed to reduce the expenses of the company during the year.

 

 

INDEX OF CHARGES:

 

S

No

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G15730575

10510884

ICICI BANK LIMITED

22/07/2014

29/07/2016

-

68500000.0

NEW NO.69, OLD NO.137A,JAWAHARLAL NEHRU ROAD, EKKATUTHANGAL CHENNAI TN600032IN

2

B60883287

10383427

ICICI BANK LIMITED

16/10/2012

-

-

6000000.0

LANDMARKRACE COURCE CIRCLE ALKAPURI BARODA GJ390015IN

3

C18676577

80038094

INDIAN OVERSEAS BANK

28/09/2005

30/11/2010

12/08/2014

24650000.0

NUNGAMBAKKAM BRANCH109, NUNGAMBAKKAM HIGH ROAD CHENNAI TN600034IN

4

B60422979

10074708

ICICI BANK LIMITED

27/09/2007

-

20/10/2012

15800000.0

"LANDMARK" RACE COURSE CIRCLE VADODARA GJ390007IN

 

 

FIXED ASSETS:

 

Tangible Assets

·         Land

·         Building

·         Office Equipments

·         Computers

·         Plant and Machinery

·         Furniture and Fittings

·         Furniture and Fixture

·         Vehicles

 

Intangible Assets

·         Software

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.87

UK Pound

1

INR 90.49

Euro

1

INR 79.91

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHK

 

 

Analysis Done by :

VVK

 

 

Report Prepared by :

NKT

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.